Skip to main content
SpringerLink
Log in

Insights on Adenomyosis Development

  • Chapter
  • First Online:
Endometriosis and Adenomyosis

  • 950 Accesses

Abstract

Adenomyosis is a gynecological condition defined as the presence of endometrial glands and stroma deep within the myometrium, causing myometrial hypertrophy, hyperplasia, and fibrosis. In the past, it was thought that adenomyosis affected almost exclusively multiparous women after 40 years, and the diagnosis was generally confirmed upon hysterectomy. Nowadays, by using imaging techniques such as transvaginal ultrasound (TVUS) and magnetic resonance imaging (MRI), adenomyosis is increasingly identified in young women with pain, abnormal uterine bleeding (AUB), and infertility or asymptomatic women. Although the pathogenesis of adenomyosis remains unclear, two main theories have been proposed: (a) invagination of the endometrial basalis into the myometrium and (b) metaplasia of displaced embryonic pluripotent Müllerian remnants or differentiation of adult stem cells. Key pathogenic mechanisms of adenomyosis include estrogen dependence, progesterone resistance, inflammation, aberrant immune responses, cell proliferation, migration, invasion, fibrosis, and neuroangiogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Change history

  • 10 September 2022

    Correction to:

References

  1. Loring M, Chen TY, Isaacson KB. A systematic review of Adenomyosis: it’s time to reassess what we thought we knew about the disease. J Minim Invasive Gynecol. 2020;28(3):644–55.

    Article  PubMed  Google Scholar 

  2. García-Solares J, Donnez J, Donnez O, Dolmans M-M. Pathogenesis of uterine adenomyosis: invagination or metaplasia? Fertil Steril. 2018;109(3):371–9.

    Google Scholar 

  3. Vannuccini S, Petraglia F. Recent advances in understanding and managing adenomyosis. F1000Res. 2019;8:F1000 Faculty Rev-283. https://doi.org/10.12688/f1000research.17242.1.

  4. Stratopoulou CA, Donnez J, Dolmans MM. Origin and pathogenic mechanisms of uterine Adenomyosis: what is known so far. Reprod Sci. 2020;28(8):2087–97.

    Article  PubMed  Google Scholar 

  5. Weiss G, Maseelall P, Schott LL, Brockwell SE, Schocken M, Johnston JM. Adenomyosis a variant, not a disease? Evidence from hysterectomized menopausal women in the study of Women’s Health Across the Nation (SWAN). Fertil Steril. 2009;91(1):201–6.

    Article  PubMed  Google Scholar 

  6. Templeman C, Marshall SF, Ursin G, Horn-Ross PL, Clarke CA, Allen M, et al. Adenomyosis and endometriosis in the California Teachers Study. Fertil Steril. 2008;90(2):415–24.

    Article  PubMed  Google Scholar 

  7. Vercellini P, Viganò P, Somigliana E, Daguati R, Abbiati A, Fedele L. Adenomyosis: epidemiological factors. Best Pract Res Clin Obstet Gynaecol. 2006;20:465–77.

    Google Scholar 

  8. Parazzini F, Vercellini P, Panazza S, Chatenoud L, Oldani S, Crosignani PG. Risk factors for adenomyosis. Hum Reprod. 1997;12(6):1275–9.

    Article  CAS  PubMed  Google Scholar 

  9. Panganamamula UR, Harmanli OH, Isik-Akbay EF, Grotegut CA, Dandolu V, Gaughan JP. Is prior uterine surgery a risk factor for adenomyosis? Obstet Gynecol. 2004;104(5):1034–8.

    Article  PubMed  Google Scholar 

  10. Taran FA, Weaver AL, Coddington CC, Stewart EA. Understanding adenomyosis: a case control study. Fertil Steril. 2010;94(4):1223–8.

    Article  PubMed  Google Scholar 

  11. Guo. The pathogenesis of Adenomyosis vis-à-vis endometriosis. J Clin Med. 2020;9(2):485.

    Article  CAS  PubMed Central  Google Scholar 

  12. Cohen I, Beyth Y, Shapira J, Tepper R, Fishman A, Cordoba M, et al. High frequency of adenomyosis in postmenopausal breast cancer patients treated with tamoxifen. Gynecol Obstet Investig. 1997;44(3):200–5.

    Article  CAS  Google Scholar 

  13. Varras M, Polyzos D, Akrivis C. Effects of tamoxifen on the human female genital tract: review of the literature. Eur J Gynaecol Oncol. 2003;24(3–4):258–68.

    CAS  PubMed  Google Scholar 

  14. Brosens I, Derwig I, Brosens J, Fusi L, Benagiano G, Pijnenborg R. The enigmatic uterine junctional zone: the missing link between reproductive disorders and major obstetrical disorders? Hum Reprod. 2010;25:569–74.

    Google Scholar 

  15. Leyendecker G, Wildt L. A new concept of endometriosis and adenomyosis: tissue injury and repair (TIAR). Horm Mol Biol Clin Investig. 2011;5(2).

    Google Scholar 

  16. Leyendecker G, Bilgicyildirim A, Inacker M, Stalf T, Huppert P, Mall G, et al. Adenomyosis and endometriosis. Re-visiting their association and further insights into the mechanisms of auto-traumatisation. An MRI study. Arch Gynecol Obstet. 2015;291(4):917–32.

    Article  CAS  PubMed  Google Scholar 

  17. Vannuccini S, Tosti C, Carmona F, Huang SJ, Chapron C, Guo SW, et al. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod Biomed Online. 2017;35(5):592–601.

    Article  CAS  PubMed  Google Scholar 

  18. Zhai J, Vannuccini S, Petraglia F, Giudice LC. Adenomyosis: mechanisms and pathogenesis. Semin Reprod Med. 2020;38(2–3):129–43.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Gargett CE. Uterine stem cells: what is the evidence? Hum Reprod Update. 2006;13(1):87–101.

    Article  Google Scholar 

  20. Chapron C, Tosti C, Marcellin L, Bourdon M, Lafay-Pillet MC, Millischer AE, et al. Relationship between the magnetic resonance imaging appearance of adenomyosis and endometriosis phenotypes. Hum Reprod. 2017;32(7):1393–401.

    Article  PubMed  Google Scholar 

  21. Bourdon M, Santulli P, Jeljeli M, Vannuccini S, Marcellin L, Doridot L, et al. Immunological changes associated with adenomyosis: a systematic review. Hum Reprod Update. 2021;27(1):108–29.

    Article  CAS  PubMed  Google Scholar 

  22. Herndon CN, Aghajanova L, Balayan S, Erikson D, Barragan F, Goldfien G, et al. Global transcriptome abnormalities of the Eutopic endometrium from women with Adenomyosis. Reprod Sci. 2016;23(10):1289–303.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Xiang Y, Sun Y, Yang B, Yang Y, Zhang Y, Yu T, et al. Transcriptome sequencing of adenomyosis eutopic endometrium: a new insight into its pathophysiology. J Cell Mol Med. 2019;23(12):8381–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Tong X, Li Z, Wu Y, Fu X, Zhang Y, Fan H. COMT 158G/A and CYP1B1 432C/G polymorphisms increase the risk of endometriosis and adenomyosis: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2014;179:17–21.

    Article  CAS  PubMed  Google Scholar 

  25. Artymuk N, Zotova O, Gulyaeva L. Adenomyosis: genetics of estrogen metabolism. Horm Mol Biol Clin Investig. 2019;37(2):2–7.

    Google Scholar 

  26. Ye H, He Y, Wang J, Song T, Lan Z, Zhao Y, et al. Effect of matrix metalloproteinase promoter polymorphisms on endometriosis and adenomyosis risk: evidence from a meta-analysis. J Genet. 2016;95(3):611–9.

    Article  CAS  PubMed  Google Scholar 

  27. Kang S, Zhao X, Xing H, Wang N, Zhou R, Chen S, et al. Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis. Environ Mol Mutagen. 2008;49(3):226–31.

    Article  CAS  PubMed  Google Scholar 

  28. Kang S, Li S-Z, Wang N, Zhou R-M, Wang T, Wang D-J, et al. Association between genetic polymorphisms in fibroblast growth factor (FGF)1 and FGF2 and risk of endometriosis and adenomyosis in Chinese women. Hum Reprod. 2010;25(7):1806–11.

    Article  CAS  PubMed  Google Scholar 

  29. Kang S, Zhao J, Liu Q, Zhou R, Wang N, Li Y. Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis. Environ Mol Mutagen. 2009;50(5):361–6.

    Article  CAS  PubMed  Google Scholar 

  30. Wang Y, Qu Y, Song W. Genetic variation in COX-2 -1195 and the risk of endometriosis and adenomyosis. Clin Exp Obstet Gynecol. 2015;42(2):168–72.

    Article  PubMed  Google Scholar 

  31. Inoue S, Hirota Y, Ueno T, Fukui Y, Yoshida E, Hayashi T, et al. Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations. Nat Commun. 2019;10(1):5785.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Liu X, Guo S-W. Aberrant immunoreactivity of deoxyribonucleic acid methyltransferases in adenomyosis. Gynecol Obstet Investig. 2012;74(2):100–8.

    Article  CAS  Google Scholar 

  33. Liu X, Nie J, Guo SW. Elevated immunoreactivity against class i histone deacetylases in adenomyosis. Gynecol Obstet Investig. 2012;74(1):50–5.

    Article  CAS  Google Scholar 

  34. Liu X, Guo S-W. A pilot study on the off-label use of valproic acid to treat adenomyosis. Fertil Steril. 2008;89(1):246–50.

    Article  CAS  PubMed  Google Scholar 

  35. Zhai J, Li S, Sen S, Opoku-Anane J, Du Y, Chen ZJ, et al. m6A RNA methylation regulators contribute to Eutopic endometrium and myometrium dysfunction in Adenomyosis. Front Genet. 2020;11(July):1–16.

    Google Scholar 

  36. Rižner TL. The important roles of steroid sulfatase and sulfotransferases in gynecological diseases. Front Pharmacol. 2016;7:30.

    Google Scholar 

  37. Kitawaki J, Noguchi T, Amatsu T, Maeda K, Tsukamoto K, Yamamoto T, et al. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol Reprod. 1997;57(3):514–9.

    Google Scholar 

  38. Kitawaki J, Kusuki I, Koshiba H, Tsukamoto K, Fushiki S, Honjo H. Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis. Fertil Steril. 1999;72(6):1100–6.

    Article  CAS  PubMed  Google Scholar 

  39. Kitawaki J, Koshiba H, Ishihara H, Kusuki I, Tsukamoto K, Honjo H. Progesterone induction of 17beta-hydroxysteroid dehydrogenase type 2 during the secretory phase occurs in the endometrium of estrogen-dependent benign diseases but not in normal endometrium. J Clin Endocrinol Metab. 2000;85(9):3292–6.

    CAS  PubMed  Google Scholar 

  40. Mehasseb MK, Panchal R, Taylor AH, Brown L, Bell SC, Habiba M. Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis. Fertil Steril. 2011;95(7):2228–35. 2235.e1

    Article  CAS  PubMed  Google Scholar 

  41. Nie J, Liu X, Guo S-W. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent. Reprod Sci. 2010;17(11):995–1005.

    Article  CAS  Google Scholar 

  42. Li JJ, Duan H, Wang S, Sun FQ, Gan L, Tang YQ, et al. Expression pattern of G-protein-coupled Estrogen receptor in myometrium of uteri with and without Adenomyosis. Biomed Res Int. 2017;2017(1):5974693.

    PubMed  PubMed Central  Google Scholar 

  43. Jiang C, Cheng Z. Update of recent studies of adenomyosis-associated dysmenorrhea. Gynecol Minim Invasive Ther. 2016;5(4):137–40.

    Article  Google Scholar 

  44. Mechsner S, Grum B, Gericke C, Loddenkemper C, Dudenhausen JW, Ebert AD. Possible roles of oxytocin receptor and vasopressin-1α receptor in the pathomechanism of dysperistalsis and dysmenorrhea in patients with adenomyosis uteri. Fertil Steril. 2010;94(7):2541–6.

    Article  CAS  PubMed  Google Scholar 

  45. Guo SW, Mao X, Ma Q, Liu X. Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor (OTR) in women with symptomatic adenomyosis. Fertil Steril. 2013;90:231–40.

    Article  Google Scholar 

  46. Zhang Y, Yu P, Sun F, Li TC, Cheng J, mei, Duan H. Expression of oxytocin receptors in the uterine junctional zone in women with adenomyosis. Acta Obstet Gynecol Scand. 2015;94(4):412–8.

    Article  CAS  PubMed  Google Scholar 

  47. Nie J, Liu X, Guo SW. Immunoreactivity of oxytocin receptor and transient receptor potential vanilloid type 1 and its correlation with dysmenorrhea in adenomyosis. Am J Obstet Gynecol. 2010;202(4):346.e1–8.

    Article  Google Scholar 

  48. Zhang Y, Yu P, Sun F, Li TC, Cheng JM, Duan H. Expression of oxytocin receptors in the uterine junctional zone in women with adenomyosis. Acta Obstet Gynecol Scand. 2015;94(4):412–8.

    Article  CAS  PubMed  Google Scholar 

  49. Guo SW, Mao X, Ma Q, Liu X. Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor (OTR) in women with symptomatic adenomyosis. Fertil Steril. 2013;99(1):231–40.

    Article  CAS  PubMed  Google Scholar 

  50. Andersson JK, Khan Z, Weaver AL, Vaughan LE, Gemzell-Danielsson K, Stewart EA. Vaginal bromocriptine improves pain, menstrual bleeding and quality of life in women with adenomyosis: a pilot study. Acta Obstet Gynecol Scand. 2019;98(10):1341–50.

    Article  CAS  PubMed  Google Scholar 

  51. Fiçicioğlu C, Tekin HI, Arioğlu PF, Okar I. A murine model of adenomyosis: the effects of hyperprolactinemia induced by fluoxetine hydrochloride, a selective serotonin reuptake inhibitor, on adenomyosis induction in Wistar albino rats. Acta Eur Fertil. 1995;26(2):75–9.

    PubMed  Google Scholar 

  52. Singtripop T, Mori T, Park MK, Sakamoto S, Kawashima S. Development of uterine adenomyosis after treatment with dopamine antagonists in mice. Life Sci. 1991;49(3):201–6.

    Article  CAS  PubMed  Google Scholar 

  53. Li C, Chen R, Jiang C, Chen L, Cheng Z. Correlation of LOX-5 and COX-2 expression with inflammatory pathology and clinical features of adenomyosis. Mol Med Rep. 2019;19(1):727–33.

    CAS  PubMed  Google Scholar 

  54. Carrarelli P, Luddi A, Funghi L, Arcuri F, Batteux F, Dela Cruz C, et al. Urocortin and corticotrophin-releasing hormone receptor type 2 mRNA are highly expressed in deep infiltrating endometriotic lesions. Reprod Biomed Online. 2016;33(4):476–83.

    Article  CAS  PubMed  Google Scholar 

  55. Carrarelli P, Yen CF, Funghi L, Arcuri F, Tosti C, Bifulco G, et al. Expression of inflammatory and neurogenic mediators in Adenomyosis. Reprod Sci. 2017;24(3):369–75.

    Article  CAS  PubMed  Google Scholar 

  56. Yang G, Im H-J, Wang JH-C. Repetitive mechanical stretching modulates IL-1beta induced COX-2, MMP-1 expression, and PGE2 production in human patellar tendon fibroblasts. Gene. 2005;363:166–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Wang F, Li H, Yang Z, Du X, Cui M, Wen Z. Expression of interleukin-10 in patients with adenomyosis. Fertil Steril. 2009;91(5):1681–5.

    Article  PubMed  Google Scholar 

  58. Guo J, Chen L, Luo N, Li C, Chen R, Qu X, et al. LPS/TLR4-mediated stromal cells acquire an invasive phenotype and are implicated in the pathogenesis of adenomyosis. Sci Rep. 2016;6:1–10.

    Google Scholar 

  59. Shen X, Duan H, Wang S, Gan L, Xu Q, Li JJ. Decreased expression of cannabinoid receptors in the eutopic and ectopic endometrium of patients with adenomyosis. Biomed Res Int. 2019;2019:5468954.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Shen X, Duan H, Wang S, Hong W, Wang YY, Lin SL. Expression of cannabinoid receptors in myometrium and its correlation with dysmenorrhea in Adenomyosis. Reprod Sci. 2019;26(12):1618–25.

    Article  CAS  PubMed  Google Scholar 

  61. Wang F, Wen Z, Li H, Yang Z, Zhao X, Yao X. Human leukocyte antigen-G is expressed by the eutopic and ectopic endometrium of adenomyosis. Fertil Steril. 2008;90(5):1599–604.

    Article  PubMed  Google Scholar 

  62. Baka S, Frangou-Plemenou M, Panagiotopoulou E, Makrakis E, Kaltsakas G, Hassiakos D, et al. The expression of human leukocyte antigens class I and II in women with endometriosis or adenomyosis. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2011;27(6):419–24.

    Article  CAS  Google Scholar 

  63. Zhou Y, Peng Y, Xia Q, Yan D, Zhang H, Zhang L, et al. Decreased Indian hedgehog signaling activates autophagy in endometriosis and adenomyosis. Reproduction. 2021;161(2):99–109.

    Article  CAS  PubMed  Google Scholar 

  64. Ota H, Maki M, Shidara Y, Kodama H, Takahashi H, Hayakawa M, Fujimori R, Kushima T, Ohtomo K. Effects of danazol at the immunologic level in patients with adenomyosis, with special reference to autoantibodies: a multi-center cooperative study. Am J Obstet Gynecol. 1992;167(2):418–6.

    Article  Google Scholar 

  65. Sun FQ, Duan H, Wang S, Li JJ. 17β-Estradiol induces Overproliferation in Adenomyotic human uterine smooth muscle cells of the junctional zone through Hyperactivation of the Estrogen receptor-enhanced RhoA/ROCK signaling pathway. Reprod Sci. 2015;22(11):1436–44.

    Article  CAS  PubMed  Google Scholar 

  66. Carrarelli P, Yen CF, Arcuri F, Funghi L, Tosti C, Wang TH, et al. Myostatin, follistatin and activin type II receptors are highly expressed in adenomyosis. Fertil Steril. 2015;104(3):744–752.e1.

    Article  CAS  PubMed  Google Scholar 

  67. Streuli I, Santulli P, Chouzenoux S, Chapron C, Batteux F. Activation of the MAPK/ERK cell-signaling pathway in uterine smooth muscle cells of women with Adenomyosis. Reprod Sci. 2015;22(12):1549–60.

    Article  CAS  PubMed  Google Scholar 

  68. Li J, Yanyan M, Mu L, Chen X, Zheng W. The expression of Bcl-2 in adenomyosis and its effect on proliferation, migration, and apoptosis of endometrial stromal cells. Pathol Res Pract. 2019;215(8):152477.

    Article  PubMed  Google Scholar 

  69. Wang B, Yang Y, Deng X, Ban Y, Chao L. Interaction of M2 macrophages and endometrial cells induces downregulation of GRIM-19 in endometria of adenomyosis. Reprod Biomed Online. 2020;41(5):790–800.

    Article  CAS  PubMed  Google Scholar 

  70. Chen Y-J, Li H-Y, Huang C-H, Twu N-F, Yen M-S, Wang P-H, et al. Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis. J Pathol. 2010;222(3):261–70.

    Article  CAS  PubMed  Google Scholar 

  71. Zheng D, Duan H, Wang S, Xu Q, Gan L, Li J, et al. FAK regulates epithelial-mesenchymal transition in adenomyosis. Mol Med Rep. 2018;18(6):5461–72.

    CAS  PubMed  PubMed Central  Google Scholar 

  72. Zhou W, Peng Z, Zhang C, Liu S, Zhang Y. ILK-induced epithelial-mesenchymal transition promotes the invasive phenotype in adenomyosis. Biochem Biophys Res Commun. 2018;497(4):950–6.

    Article  CAS  PubMed  Google Scholar 

  73. Khan KN, Kitajima M, Hiraki K, Fujishita A, Nakashima M, Masuzaki H. Involvement of hepatocyte growth factor-induced epithelial-mesenchymal transition in human adenomyosis. Biol Reprod. 2015;92(2):35.

    Article  CAS  PubMed  Google Scholar 

  74. Hu R, Peng G-Q, Ban D-Y, Zhang C, Zhang X-Q, Li Y-P. High-expression of Neuropilin 1 correlates to Estrogen-induced epithelial-mesenchymal transition of endometrial cells in Adenomyosis. Reprod Sci. 2020;27(1):395–403.

    Article  CAS  PubMed  Google Scholar 

  75. Qi S, Zhao X, Li M, Zhang X, Lu Z, Yang C, et al. Aberrant expression of Notch1/numb/snail signaling, an epithelial mesenchymal transition related pathway, in adenomyosis. Reprod Biol Endocrinol. 2015;13:96.

    Article  PubMed  PubMed Central  Google Scholar 

  76. An M, Li D, Yuan M, Li Q, Zhang L, Wang G. Different macrophages equally induce EMT in endometria of adenomyosis and normal. Reproduction. 2017;154(1):79–92.

    Article  CAS  PubMed  Google Scholar 

  77. Liu X, Shen M, Qi Q, Zhang H, Guo S-W. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis. Hum Reprod. 2016;31(4):734–49.

    Article  CAS  PubMed  Google Scholar 

  78. Zhou S, Yi T, Liu R, Bian C, Qi X, He X, et al. Proteomics identification of annexin A2 as a key mediator in the metastasis and proangiogenesis of endometrial cells in human adenomyosis. Mol Cell Proteomics. 2012;11(7):M112.017988.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Chen N, Du B, Zhou H, Shen F, Li J, Xie Z. Abnormal expression of Nrf2 may play an important role in the pathogenesis and development of adenomyosis. PLoS One. 2017;12(8):e0182773.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Tokyol C, Aktepe F, Dilek FH, Sahin O, Arioz DT. Expression of cyclooxygenase-2 and matrix metalloproteinase-2 in adenomyosis and endometrial polyps and its correlation with angiogenesis. Int J Gynecol Pathol Off J Int Soc Gynecol Pathol. 2009;28(2):148–56.

    Article  Google Scholar 

  81. Li T, Li Y-G, Pu D-M. Matrix metalloproteinase-2 and -9 expression correlated with angiogenesis in human adenomyosis. Gynecol Obstet Investig. 2006;62(4):229–35.

    Article  CAS  Google Scholar 

  82. Cheong M-L, Lai T-H, Wu W-B. Connective tissue growth factor mediates transforming growth factor β-induced collagen expression in human endometrial stromal cells. PLoS One. 2019;14(1):e0210765.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Harmsen MJ, Wong CFC, Mijatovic V, Griffioen AW, Groenman F, Hehenkamp WJK, et al. Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review. Hum Reprod Update. 2019;25(5):647–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Yalaza C, Canacankatan N, Gürses İ, Aytan H, Taşdelen B. Altered VEGF, Bcl-2 and IDH1 expression in patients with adenomyosis. Arch Gynecol Obstet. 2020;302(5):1221–7.

    Article  CAS  PubMed  Google Scholar 

  85. Goteri G, Lucarini G, Montik N, Zizzi A, Stramazzotti D, Fabris G, et al. Expression of vascular endothelial growth factor (VEGF), hypoxia inducible factor-1alpha (HIF-1alpha), and microvessel density in endometrial tissue in women with adenomyosis. Int J Gynecol Pathol Off J Int Soc Gynecol Pathol. 2009;28(2):157–63.

    Article  Google Scholar 

  86. Orazov MR, Radzinsky VE, Nosenko EN, Khamoshina MB, Dukhin AO, Lebedeva MG. Immune-inflammatory predictors of the pelvic pain syndrome associated with adenomyosis. Gynecol Endocrinol. 2017;33:44–6.

    Article  CAS  PubMed  Google Scholar 

  87. Moalem G, Tracey DJ. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev. 2006;51(2):240–64.

    Article  CAS  PubMed  Google Scholar 

  88. Anaf V, Simon P, El Nakadi I, Fayt I, Simonart T, Buxant F, et al. Hyperalgesia, nerve infiltration and nerve growth factor expression in deep adenomyotic nodules, peritoneal and ovarian endometriosis. Hum Reprod. 2002;17(7):1895–900.

    Article  PubMed  Google Scholar 

  89. Li Y, Zhang S, Zou S, Xia X, Bao L. Accumulation of nerve growth factor and its receptors in the uterus and dorsal root ganglia in a mouse model of adenomyosis. Reprod Biol Endocrinol. 2011;9(1):30.

    Google Scholar 

  90. Takeuchi A, Koga K, Miyashita M, Makabe T, Sue F, Harada M, et al. Dienogest reduces proliferation, NGF expression and nerve fiber density in human adenomyosis. Eur J Obstet Gynecol Reprod Biol. 2016;207:157–61.

    Google Scholar 

  91. Hirata T, Izumi G, Takamura M, Saito A, Nakazawa A, Harada M, et al. Efficacy of dienogest in the treatment of symptomatic adenomyosis: a pilot study. Gynecol Endocrinol. 2014;30(10):726–9.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Experimental, Clinical and Biomedical Sciences, Careggi University Hospital, Florence, Italy

    Silvia Vannuccini & Sara Clemenza

Authors
  1. Silvia Vannuccini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sara Clemenza
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Silvia Vannuccini .

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, Bezmialem Vakif University Medical Faculty, Istanbul, Turkey

    Engin Oral

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Vannuccini, S., Clemenza, S. (2022). Insights on Adenomyosis Development. In: Oral, E. (eds) Endometriosis and Adenomyosis. Springer, Cham. https://doi.org/10.1007/978-3-030-97236-3_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-97236-3_31

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-97235-6

  • Online ISBN: 978-3-030-97236-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation